Predict your next investment

Private Equity
cobroventures.com

See what CB Insights has to offer

Investments

8

Portfolio Exits

2

Funds

1

About Cobro Ventures

Cobro Ventures is a management company that encompasses a diversified portfolio of investments. The firm's investments range from new start-ups to enterprises that have become public and been acquired.

Cobro Ventures Headquarter Location

Washington, DC,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cobro Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Cobro Ventures in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Cobro Ventures News

TechsoMed Raises $7 Million Series B financing

Mar 4, 2021

Israel: TechsoMed, developer of first of its kind AI and Algorithm powered real-time tissue damage imaging technology (BioTrace), announced today it has closed a US$7 Million Series B equity financing round, led by Axil Capital with the participation of Yongjin Capital, Cobro Ventures, Magna Capital Partners and Radianx Capital, along with the company’s existing investors – Johnson & Johnson Innovation – JJDC, Inc., and NextLeap Ventures. Following clinical and regulatory approval, the company’s technology has the potential to help physicians ensure treatment accuracy and increase treatment efficacy. TechsoMed is collaborating with leading medical centers world-wide, in efforts to secure regulatory approval for its BioTrace system in liver tumor ablation through the De Novo process established by the FDA. In parallel, the BioTrace system is also being developed to support cardiac and pain ablation procedures. “We are very grateful to both our new and existing investors for sharing our vision and recognizing the valuable impact that our technology brings. Coming from diverse regional markets such as the U.S., Japan, China and the EU, our investors act as driving force towards achieving our goals for scaling our technology and company,” said Yossi Abu, CEO, TechsoMed.” With our BioTrace solution and advanced algorithm and image processing technologies, physicians will be able to see more in real time. We hope to eliminate the guess work in ablation therapy.”

Cobro Ventures Investments

8 Investments

Cobro Ventures has made 8 investments. Their latest investment was in TechsoMed as part of their Series B on March 3, 2021.

CBI Logo

Cobro Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/3/2021

Series B

TechsoMed

$7M

Yes

2

1/8/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

6/16/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

3/25/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/23/2019

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/3/2021

1/8/2021

6/16/2020

3/25/2020

7/23/2019

Round

Series B

Series A

Series B

Series A

Series C

Company

TechsoMed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$7M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

10

10

Cobro Ventures Portfolio Exits

2 Portfolio Exits

Cobro Ventures has 2 portfolio exits. Their latest portfolio exit was C4 Therapeutics on October 02, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/2/2020

IPO

$991

2

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

10/2/2020

00/00/0000

Exit

IPO

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Sources

2

10

Cobro Ventures Fund History

1 Fund History

Cobro Ventures has 1 fund, including Cobro Ventures Opportunity Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Cobro Ventures Opportunity Fund

1

Closing Date

Fund

Cobro Ventures Opportunity Fund

Fund Type

Status

Amount

Sources

1

Cobro Ventures Team

4 Team Members

Cobro Ventures has 4 team members, including current Chief Executive Officer, Marc Cohen.

Name

Work History

Title

Status

Alain Cohen

Founder

Current

Marc Cohen

Chief Executive Officer

Current

Alberto Morales

Chief Technology Officer

Current

Todd Kaloudis

Managing Director

Current

Name

Alain Cohen

Marc Cohen

Alberto Morales

Todd Kaloudis

Work History

Title

Founder

Chief Executive Officer

Chief Technology Officer

Managing Director

Status

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.